Is Krystexxa Covered By Medicare?

Rakibul Hasan

Chief Editor of - Free Insurance Tips

Meet Rakibul Hasan, the visionary leader and founder of Freeinsurancetips. With over a decade of experience in the insurance sector, Rakibul is dedicated to empowering...Read more

Krystexxa, also known as pegloticase, is a medication used to treat gout. The drug is administered intravenously and works by breaking down uric acid in the body. However, the cost of Krystexxa can be quite high, leaving many people wondering if it is covered by Medicare.

Medicare is a federal health insurance program that provides coverage for individuals over the age of 65, as well as those with certain disabilities. While Medicare does cover a wide range of medical treatments and medications, not all drugs are covered. This has left many people questioning whether or not Krystexxa is covered by Medicare and what options are available for those who need the drug but cannot afford it. In this article, we will explore the coverage options for Krystexxa under Medicare and provide information on alternative options for those who may not be covered.

Is Krystexxa Covered by Medicare?
Yes, Krystexxa is covered by Medicare Part B for patients who meet certain criteria. The drug is typically used to treat chronic gout in patients who have not responded to other medications. Medicare may require prior authorization or step therapy before covering the cost of Krystexxa. Patients are advised to check with their healthcare provider and insurance plan for specific coverage details.

Is Krystexxa Covered by Medicare?

If you are suffering from gout, Krystexxa may be a viable treatment option. However, the cost of the medication can be a concern for many patients. One question that often arises is whether Krystexxa is covered by Medicare. In this article, we will explore the coverage options available for Krystexxa under Medicare.

What is Krystexxa?

Krystexxa is a medication used to treat chronic gout. It works by breaking down uric acid in the body, which can help reduce the frequency and severity of gout attacks. Krystexxa is administered intravenously and is typically given every two weeks.

How is Krystexxa Covered by Medicare?

Krystexxa is covered by Medicare under Part B, which covers medically necessary services and supplies. This includes injectable drugs like Krystexxa that are administered by a healthcare provider. However, there may be certain restrictions and limitations on coverage.

What are the Restrictions on Krystexxa Coverage?

Medicare may require prior authorization for Krystexxa treatment. This means that your healthcare provider will need to submit a request to Medicare explaining why Krystexxa is medically necessary for your condition. Additionally, Medicare may limit the amount of Krystexxa that is covered per treatment or per year.

What are the Costs of Krystexxa under Medicare?

Under Medicare Part B, you are responsible for paying 20% of the Medicare-approved amount for Krystexxa. The remaining 80% is covered by Medicare. However, if you have a Medicare Advantage plan, your costs may be different. You should check with your plan to determine your specific coverage and costs.

Benefits of Krystexxa

Krystexxa has been shown to be effective in treating chronic gout, which can be a debilitating condition. It can help reduce the frequency and severity of gout attacks, which can improve your overall quality of life. Additionally, Krystexxa may be a good option for patients who have not responded well to other gout treatments.

How does Krystexxa Compare to Other Gout Treatments?

Krystexxa is a unique treatment option for chronic gout that works by breaking down uric acid in the body. Other gout treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine, work by reducing inflammation and pain. Krystexxa may be a good option for patients who have not responded well to these other treatments.

What are the Side Effects of Krystexxa?

Like all medications, Krystexxa can cause side effects. The most common side effects include infusion reactions, gout flares, and nausea. However, these side effects are typically mild to moderate in severity and can be managed with proper medical care.

Conclusion

If you are considering Krystexxa as a treatment option for your chronic gout, it is important to understand your coverage options under Medicare. While Krystexxa is covered under Medicare Part B, there may be restrictions and limitations on coverage. It is important to work with your healthcare provider and Medicare to determine your specific coverage and costs.

Contents

Frequently Asked Questions

Frequently Asked Questions

Is Krystexxa Covered by Medicare?

Yes, Krystexxa is covered by Medicare Part B and Part D, but there may be some restrictions and limitations that apply. Krystexxa is used to treat chronic gout in adults who have not responded to other treatments. Medicare may cover the cost of Krystexxa if it is deemed medically necessary by a healthcare provider.

It is important to note that Medicare coverage for Krystexxa may vary depending on the specific plan and the patient’s individual circumstances. Patients should consult with their healthcare provider and their Medicare plan to determine if Krystexxa is covered and what their out-of-pocket costs may be.

What are the Requirements for Medicare Coverage of Krystexxa?

Medicare coverage for Krystexxa requires that the patient has been diagnosed with chronic gout and has not responded to other treatments. The patient must also have a Medicare plan that covers Part B or Part D prescription drugs. Additionally, the healthcare provider prescribing Krystexxa must be enrolled in Medicare and must meet certain requirements for administering the medication.

Patients who meet these requirements may be eligible for Medicare coverage of Krystexxa, but it is important to note that there may be limits on the dosage and duration of treatment that are covered. Patients should consult with their healthcare provider and their Medicare plan to determine their eligibility and coverage options.

What is the Cost of Krystexxa with Medicare Coverage?

The cost of Krystexxa with Medicare coverage may vary depending on the patient’s specific plan and the dosage and duration of treatment that are covered. Patients may be responsible for paying a portion of the cost of Krystexxa, including deductibles, copayments, and coinsurance. These costs may be higher if the patient receives Krystexxa in a hospital outpatient setting rather than a doctor’s office or clinic.

Patients are encouraged to consult with their healthcare provider and their Medicare plan to determine their out-of-pocket costs for Krystexxa and any other treatments they may receive. Patients may also be eligible for financial assistance programs that can help cover the cost of Krystexxa or other medications.

How Do I Apply for Medicare Coverage of Krystexxa?

To apply for Medicare coverage of Krystexxa, patients should consult with their healthcare provider to determine if the medication is medically necessary and appropriate for their condition. The healthcare provider can then submit a claim for coverage to Medicare on behalf of the patient.

Patients should also ensure that their Medicare plan covers Part B or Part D prescription drugs and that their healthcare provider is enrolled in Medicare and meets the requirements for administering Krystexxa. Patients may also need to provide additional information or documentation to support their claim for coverage.

What Other Options are Available if Krystexxa is Not Covered by Medicare?

If Krystexxa is not covered by Medicare or if the patient is not eligible for Medicare coverage, there may be other options available to help cover the cost of the medication. Patients can consult with their healthcare provider and their pharmacy to explore options such as financial assistance programs, patient assistance programs, and drug discount programs.

Patients may also consider alternative treatments for chronic gout, such as lifestyle changes, pain management techniques, and other medications that may be covered by their Medicare plan. Patients should work closely with their healthcare provider to determine the best course of treatment for their individual needs and circumstances.

Krystexxa Chronic Gout Medication Gets Expanded FDA Approval

Ultimately, the answer to whether Krystexxa is covered by Medicare depends on a number of factors, including individual health plans, medical necessity, and the prescribing physician’s experience and qualifications. However, for patients suffering from gout, Krystexxa can be a life-changing treatment option that provides relief when other medications have failed. While the cost of Krystexxa can be high, for those who are eligible for Medicare coverage, the drug may be a viable option for managing the painful symptoms of gout.

Overall, it is important for patients to work closely with their healthcare providers to determine if Krystexxa is right for them and to explore all available options for coverage and financial assistance. With the right support and guidance, patients with gout can find relief and improve their quality of life with Krystexxa, and Medicare may be one avenue to explore for those seeking coverage for this innovative treatment.

Rakibul HasanChief Editor of - Free Insurance Tips

Meet Rakibul Hasan, the visionary leader and founder of Freeinsurancetips. With over a decade of experience in the insurance sector, Rakibul is dedicated to empowering individuals to make well-informed decisions. Guided by his passion, he has assembled a team of seasoned insurance professionals committed to simplifying the intricate world of insurance for you.

Latest Posts by Rakibul Hasan